HCA
NYSE · Health Care
Hca Healthcare Inc
$433.66
-1.95 (-0.45%)
HCA News30 articles
HCA Healthcare Cuts Jobs as Exchange Mix Pressures Earnings
HCA Healthcare cut a small percentage of corporate roles as it grapples with a $400 million exchange-related earnings drag and lowered its 2026 EBITDA outlook. Shares slipped 0.5%.
Universal Health Services Slumps on Profit Warning; Buybacks Lift EPS
Universal Health Services shares dropped 5% in after-hours trading after the hospital operator lowered its 2026 profit outlook, citing Medicaid reimbursement uncertainty. Q2 EPS beat estimates but growth was mostly from share repurchases.
Intuitive Surgical Stock Dips on Slower H2 Growth Outlook Despite Q2 Beat
Intuitive Surgical shares dropped 11.3% premarket as the company's outlook for slower second-half da Vinci procedure growth overshadowed a strong Q2 earnings beat.
Intuitive Surgical Dips After Q2 Beat, Soft H2 Outlook Weighs
Intuitive Surgical (ISRG) shares dropped over 10% in after-hours trading despite a Q2 earnings beat, as the company's steady 2026 procedure guidance suggests a slowdown in the second half.
GE HealthCare Sheds $1.7B After HCA Warning on Surgery Volumes
GE HealthCare shares tumbled 5.6% on Tuesday, erasing $1.7 billion in market value, after HCA Healthcare reported lower surgery volumes and a $400 million hit from a weaker payer mix.
Intuitive Surgical Drops 6% After HCA Surgery Data Raises Q2 Concerns
Intuitive Surgical shares dropped 6% following HCA Healthcare's Q2 surgery volume decline, intensifying scrutiny ahead of its own earnings report.
Select Medical Ends NYSE Listing After $3.9B Buyout Nears Cash Price
Select Medical's stock traded at $16.51, just above the $16.50 cash buyout, before NYSE halted trading and delisted shares after the merger closed July 1.
HCA Healthcare Shares Slide on Patient Volume Concerns Despite Earnings Beat
HCA Healthcare shares dropped 8.8% after first-quarter profit narrowly beat estimates, but weaker patient volumes and payer-mix concerns rattled investors.
Nasdaq Futures Climb on Intel's Strong Outlook; Dow Dips on Oil Surge
Nasdaq 100 futures gained 172 points driven by Intel's strong Q2 forecast, while Dow futures fell 58 points as oil prices climbed above $105 a barrel.
HCA Healthcare Holds Gains After Strong Profit Outlook, $10B Buyback
HCA Healthcare stock maintained after-hours gains after a sharp rally, fueled by an upbeat profit outlook and a massive new buyback authorization. Investors now eye key economic data.
Tenet Healthcare Soars on Strong Q4, Upbeat 2026 Profit Forecast
Tenet Healthcare shares surged 16% after posting robust fourth-quarter earnings and raising its 2026 adjusted EBITDA outlook to $4.485–$4.785 billion. The company flagged a potential $250 million headwind from expiring ACA subsidies.
S&P 500 Dips 0.6% as Healthcare Rout Offsets Energy Gains
The S&P 500 slipped 0.6% to 7,673.52, as a healthcare selloff, sparked by Novartis's failed drug trial, offset energy gains. The Dow fell twice as much, highlighting market dispersion.
Spire Healthcare's 250p Offer: A Familiar Price, New Dynamics
Spire Healthcare accepted a 250p cash offer, leaving a 5% spread. But history shows the same price failed in 2021, and current backing is below that threshold.
Healthcare Leads ASX Rotation as CSL Rebounds; Banks Struggle
Healthcare surged 9.2% on the ASX this week, led by CSL's strong results, while banks fell 5.1%. CPI and earnings will test the market next week.
ASX Weekly Wrap: Healthcare Surge, CPI Test Ahead
Healthcare and materials led a mixed ASX week, while rate-sensitive sectors fell. CPI data and a dense results calendar now set the next test.
S&P 500 Recovers Most of Tuesday's Loss, Healthcare Leads as Tech Lags
The S&P 500 bounced back on Wednesday, recovering most of Tuesday's decline, but leadership shifted to healthcare as technology remained flat.
SoundHound AI Hits 52-Week Low Despite Healthcare AI Expansion
SoundHound AI dropped 6.4% to $5.84, reaching a new 52-week low, despite MUSC Health expanding its AI agent deployment. The market remains focused on revenue quality and the pending LivePerson merger.
GE HealthCare Stock Jumps on Record Orders, Q2 Beat
GE HealthCare shares jumped 9.9% after Q2 earnings beat estimates and orders hit a record $23.9 billion. The stock rose to $70.43 premarket, though it remains 22% below its January high.
Molina Healthcare Shares Tumble as First-Half EPS Covers 73.5% of 2026 Floor
Molina Healthcare shares fell 9.4% after hours despite an earnings beat, as first-half adjusted EPS of $3.86 covers 73.5% of the 2026 floor, leaving a $1.39 gap to the full-year floor.
EGYM-Playlist $7.5B Merger Targets Healthcare and Corporate Fitness Spend
EGYM's $7.5 billion merger with Playlist aims to tap into healthcare and corporate budgets, leveraging data and connected fitness to unlock new revenue streams beyond memberships.
Abbott Leads Healthcare Surge as Insurers Show Mixed Results
Abbott Laboratories surged 10.9% despite a modest earnings beat, while UnitedHealth rose 2.6% on a larger beat. The healthcare sector ETF XLV gained 2.2%.
Healthcare Earnings Test: J&J, UnitedHealth, Abbott in Focus After Sector's 9% Drop
Major healthcare stocks report this week as the sector's 9% earnings decline goes under the microscope. J&J, UnitedHealth, and Abbott are key to determining if the drop is real or just a one-off.
Alignment Healthcare Stock Plunges 16.7% on Whistleblower Suit Alleging Expense Misreporting
Alignment Healthcare shares dropped 16.7% on July 8, 2026, following a whistleblower lawsuit from a former executive alleging expense misreporting. The company denies the claims and vows to defend itself.
Lilly's GLP-1 Dominance Drives Near-Record Close, But Healthcare Rally Broadens
Eli Lilly closed near a record as XLV gained 2.65%, but other healthcare stocks like Johnson & Johnson and AbbVie drove more of the ETF's rise. Attention now turns to Lilly's $50 Medicare obesity drug offer and generic tirzepatide filings.
Eli Lilly Surge Lifts Healthcare ETF on GLP-1 Access and Drug Approval
Eli Lilly shares jumped 6.5% on Medicare GLP-1 access and a positive EU drug opinion, lifting the healthcare sector ETF XLV by 2.4%.
AbbVie Nears $10.9B Apogee Takeover, Healthcare Stocks in Focus
AbbVie is reportedly close to acquiring Apogee Therapeutics for $10.9 billion in cash, offering a roughly 60% premium. A deal could be announced Monday, putting healthcare stocks in the spotlight.
AI-Driven Healthcare Fraud Surge Strains Insurers, Coverage Gaps Widen
AI is fueling healthcare fraud with fake medical records and bot calls, driving up costs and exposing coverage gaps as insurers scramble to adapt.
Novo Nordisk Shares Rally as Healthcare Sector Lifts OMXC25
Novo Nordisk B shares rose 5% to 294.4 Danish crowns, leading the OMXC25 higher as healthcare stocks gained. The rally came amid a cyber incident and ongoing competition with Eli Lilly in oral obesity drugs.
Alignment Healthcare Surges 25% on Raised 2026 Guidance, Strong Q1
Alignment Healthcare stock surged 25% after raising its 2026 guidance and reporting strong Q1 earnings, driven by disciplined growth and stable utilization trends.
Dow Hits Record as Oil Retreats, Healthcare Surges; Broadcom Disappoints
The Dow rose 1.60% to a record 51,496.83 as oil prices eased and hopes for an end to the Iran war lifted healthcare and financial shares, offsetting weakness in AI stocks led by Broadcom.